tiprankstipranks
Advertisement
Advertisement

MREO Stock Latest News

JPMorgan downgrades Mereo to Underweight on regulatory uncertainty
The FlyJPMorgan downgrades Mereo to Underweight on regulatory uncertainty
2d ago
MREO
Mereo BioPharma Granted Nasdaq Extension to Regain Compliance
PremiumCompany Announcements
Mereo BioPharma Granted Nasdaq Extension to Regain Compliance
2d ago
8K
MREO
Mereo BioPharma downgraded to Underweight from Neutral at JPMorgan
PremiumThe Fly
Mereo BioPharma downgraded to Underweight from Neutral at JPMorgan
3d ago
MREO
Mereo Biopharma Grants Sentynl Rights to Alvelestat Therapy
PremiumCompany Announcements
Mereo Biopharma Grants Sentynl Rights to Alvelestat Therapy
10d ago
8K
MREO
Mereo BioPharma reports Q2 EPS (1c), consensus (1c)
PremiumThe Fly
Mereo BioPharma reports Q2 EPS (1c), consensus (1c)
10d ago
MREO
Mereo BioPharma licenses alvelestat to Sentynl Therapeutics in the U.S.
PremiumThe FlyMereo BioPharma licenses alvelestat to Sentynl Therapeutics in the U.S.
10d ago
MREO
MREO Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
MREO Upcoming Earnings Report: What to Expect?
3M ago
MREO
Mereo BioPharma Shareholders Approve All AGM Resolutions
Premium
Company Announcements
Mereo BioPharma Shareholders Approve All AGM Resolutions
3M ago
8K
MREO
Mereo BioPharma reports Q1 EPS (1c), consensus 0c
PremiumThe Fly
Mereo BioPharma reports Q1 EPS (1c), consensus 0c
3M ago
MREO
Mereo Biopharma Announces Upcoming Board Change, Ensuring Continuity
PremiumCompany Announcements
Mereo Biopharma Announces Upcoming Board Change, Ensuring Continuity
5M ago
8K
MREO
Shareholders Sue Mereo BioPharma (MREO) Over Brittle Bone Drug Claims
PremiumMarket News
Shareholders Sue Mereo BioPharma (MREO) Over Brittle Bone Drug Claims
5M ago
NVS
MREO
Mereo BioPharma downgraded to Neutral from Overweight at JPMorgan
PremiumThe Fly
Mereo BioPharma downgraded to Neutral from Overweight at JPMorgan
5M ago
MREO
Mereo BioPharma downgraded to Neutral from Overweight at JPMorgan
PremiumThe FlyMereo BioPharma downgraded to Neutral from Overweight at JPMorgan
5M ago
MREO
Balanced Risk-Reward Amid Clinical Uncertainty: Maintaining Hold on Mereo BioPharma
Premium
Ratings
Balanced Risk-Reward Amid Clinical Uncertainty: Maintaining Hold on Mereo BioPharma
5M ago
MREO
Mereo BioPharma repors FY25 EPS (5c), consenus (4c)
Premium
The Fly
Mereo BioPharma repors FY25 EPS (5c), consenus (4c)
5M ago
MREO
Mereo BioPharma sees cash runway into mid-2027
PremiumThe Fly
Mereo BioPharma sees cash runway into mid-2027
5M ago
MREO
Mereo BioPharma Lawsuit Alleges Misleading Trial Claims After Setrusumab Study Failures
PremiumClass Action
Mereo BioPharma Lawsuit Alleges Misleading Trial Claims After Setrusumab Study Failures
6M ago
MREO
Mereo BioPharma Group PLC Faces Lawsuit Following Trial Results
PremiumClass Action
Mereo BioPharma Group PLC Faces Lawsuit Following Trial Results
6M ago
MREO
Mereo BioPharma Receives Nasdaq Minimum Bid Price Notice
PremiumCompany Announcements
Mereo BioPharma Receives Nasdaq Minimum Bid Price Notice
6M ago
8K
MREO
Largest borrow rate increases among liquid names
PremiumThe FlyLargest borrow rate increases among liquid names
7M ago
RR
ENB
Mereo BioPharma Issues Corporate Update on Pipeline and Cash
Premium
Company Announcements
Mereo BioPharma Issues Corporate Update on Pipeline and Cash
7M ago
8K
MREO
Mereo BioPharma sees cash runway into mid-2027
Premium
The Fly
Mereo BioPharma sees cash runway into mid-2027
7M ago
MREO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >